Literature DB >> 18986660

Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Ingeborg Zehbe1, Christina Richard, Correne A DeCarlo, Anny Shai, Paul F Lambert, Hava Lichtig, Massimo Tommasino, Levana Sherman.   

Abstract

L83V-related variants of human papillomavirus (HPV) 16 E6, exemplified by the Asian-American variant Q14H/H78Y/L83V, were shown to be more prevalent than E6 prototype in progressing lesions and cervical cancer. We evaluated functions relevant to carcinogenesis for the E6 variants L83V, R10/L83V and Q14H/H78Y/L83V as well as the prototype in a model of human normal immortalized keratinocytes (NIKS). All E6 expressing NIKS equally abrogated growth arrest and DNA damage responses. Organotypic cultures derived from these keratinocytes demonstrated hyperplasia and aberrantly expressed keratin 5 in the suprabasal compartment. In contrast, differentiation and induction of apoptosis varied. The E6 variant rafts expressed keratin 10 in nearly all suprabasal cells while the prototype raft showed keratin 10 staining in a subset of suprabasal cells only. In addition, E6 variant NIKS expressing R10G/L83V and Q14H/H78Y/L83V were more prone to undergo cell-detachment-induced apoptosis (anoikis) than NIKS expressing E6 prototype. The combined differentiation and apoptosis pattern of high-risk E6 variants, especially of Q14H/H78Y/L83V, may reflect a phenotype beneficial to carcinogenesis and viral life cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18986660      PMCID: PMC2945146          DOI: 10.1016/j.virol.2008.09.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  70 in total

1.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities.

Authors:  P Londesborough; L Ho; G Terry; J Cuzick; C Wheeler; A Singer
Journal:  Int J Cancer       Date:  1996-10-21       Impact factor: 7.396

3.  Improved program for the analysis of DNA histograms.

Authors:  M G Ormerod; A W Payne; J V Watson
Journal:  Cytometry       Date:  1987-11

Review 4.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

5.  The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

Authors:  Maria Filippova; Helen Song; Jodi L Connolly; Terence S Dermody; Penelope J Duerksen-Hughes
Journal:  J Biol Chem       Date:  2002-04-04       Impact factor: 5.157

6.  Human papillomavirus type-16 variants in Quechua aboriginals from Argentina.

Authors:  María Alejandra Picconi; Lidia Virginia Alonio; Laura Sichero; Viviana Mbayed; Luisa Lina Villa; Jorge Gronda; Rodolfo Campos; Angélica Teyssié
Journal:  J Med Virol       Date:  2003-04       Impact factor: 2.327

7.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis.

Authors:  Sergio Ruiz; Mirentxu Santos; Carmen Segrelles; Hugo Leis; José Luis Jorcano; Anton Berns; Jesús M Paramio; Marc Vooijs
Journal:  Development       Date:  2004-06       Impact factor: 6.868

9.  Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D.

Authors:  D K Trask; M T Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

View more
  28 in total

1.  HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.

Authors:  Rosemary E Zuna; Erin Tuller; Nicolas Wentzensen; Cara Mathews; Richard A Allen; Rebecca Shanesmith; S Terence Dunn; Michael A Gold; Sophia S Wang; Joan Walker; Mark Schiffman
Journal:  Infect Agent Cancer       Date:  2011-10-28       Impact factor: 2.965

2.  A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.

Authors:  Joshua Hatterschide; Alexis C Brantly; Miranda Grace; Karl Munger; Elizabeth A White
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

4.  Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.

Authors:  Yunying Zhou; Qishu Zhang; Ge Gao; Xiaoli Zhang; Yafei Liu; Shoudao Yuan; Xiaowei Wang; Jason J Chen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

5.  Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.

Authors:  Tamás Gáll; Andrea Kis; Tímea Zsófia Tatár; Gábor Kardos; Lajos Gergely; Krisztina Szarka
Journal:  Med Microbiol Immunol       Date:  2013-05-07       Impact factor: 3.402

6.  The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes.

Authors:  Sarah Niccoli; Suraj Abraham; Christina Richard; Ingeborg Zehbe
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.

Authors:  Joshua Hatterschide; Amelia E Bohidar; Miranda Grace; Tara J Nulton; Hee Won Kim; Brad Windle; Iain M Morgan; Karl Munger; Elizabeth A White
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205

8.  Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.

Authors:  Ingeborg Zehbe; Hava Lichtig; Ashley Westerback; Paul F Lambert; Massimo Tommasino; Levana Sherman
Journal:  Mol Cancer       Date:  2011-06-24       Impact factor: 27.401

9.  Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants.

Authors:  Ivan Sabol; Mihaela Matovina; Ali Si-Mohamed; Magdalena Grce
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes.

Authors:  Melissa Togtema; Samuel Pichardo; Robert Jackson; Paul F Lambert; Laura Curiel; Ingeborg Zehbe
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.